Controversial US-backed vaccine trial in African newborns halted
Solo lo publica The Guardian: sin contraste todavía
Ningún otro medio de los que seguimos ha contado esta noticia, así que no hay versiones que comparar. Si otros la publican o aparecen datos que la contrasten, pasará a la comparativa.
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.” Continue reading...
Cambios detectados
-
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It
iswas “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.” Continue reading...Ver versiones y huellas
Ficha de captura
- Fuente
- https://www.theguardian.com/world/2026/oct/21/us-vaccine-trial-african-newborns-hepatitis-b
- Publicado
- 21/10/2026 17:18 UTC
- Capturada
- 21/10/2026 17:39 UTC
- Huella del texto
1738fbc19a3dea41· 846 palabras- Cambios detectados
- 1
- Copia de archivo
- Wayback Machine ↗